Poonam Jethanandani

Poonam Jethanandani serves as the Director of Regulatory CMC at Pharmacyclics, an AbbVie Company, since August 2013, bringing extensive experience in regulatory affairs spanning over two decades. Prior roles include Associate in Regulatory Affairs at Vical, Regulatory Analyst at Pfizer, and Senior Associate in Regulatory Affairs at BioMarin Pharmaceutical, where responsibilities included leading regulatory strategies for Aldurazyme®, a treatment for Mucopolysaccharidosis. Earlier technical expertise was developed at Bio-Rad Laboratories as a Senior Technical Support Consultant, with a focus on the BioPlex® Immunoassay system. Poonam's research background includes positions as a Postdoctoral Fellow at UCSF and Northwestern University, focusing on gene regulation, reinforced by a PhD in Life Sciences from the All India Institute of Medical Sciences and an Advanced Certificate in Regulatory Affairs from San Diego State University.